Key result
The systemic immune-inflammation index (SII) is a reliable biomarker for predicting short-term outcomes, including 30-day mortality and neurological dysfunction, after ATAAD repair.
Why the study?
Does the systemic immune-inflammation index predict short-term outcomes in patients undergoing surgery for acute type A aortic dissection?
Does the systemic immune-inflammation index predict short-term outcomes in patients undergoing surgery for acute type A aortic dissection?
Answers are grounded in this paper and cite their sources.
The systemic immune-inflammation index is a promising biomarker for predicting short-term postoperative outcomes and aiding risk stratification in patients undergoing acute type A aortic dissection repair.
The retrospectively presented by Xu et al. assessed the value of the systemic immune-inflammation index (SII) in the prediction of short-term outcomes in patients undergoing surgery for acute type A aortic dissection (ATAAD). The authors concluded that SII is a reliable biomarker that can predict postoperative short-term outcomes and this marker could be potentially applied to stratification and patient selection with ATAAD. Although the study is retrospective, it is well-matched and conducted in a large volume center and the surgical technique was standard for all procedures. In addition, there was no statistical difference in cardiopulmonary bypass, aortic cross-clamp and deep hypothermic time, comorbidities, blood and blood products transfusion between the study groups. In addition, 90.7% of patients underwent elephant trunk technique for ATAAD repair, while the 30-day mortality and postoperative temporary and permanent neurological dysfunctions were 14.8% and 11.1%, respectively. Randomized controlled and prospective studies are warranted to clarify these well-documented results to apply this useful biomarker in clinical practice for patients with the acute aortic syndrome.
No takes yet. Share an insight, caveat, or question.
Samanidis et al. (2022) conducted an editorial in Acute type A aortic dissection (ATAAD). Systemic immune-inflammation index (SII) was evaluated on Short-term outcomes (30-day mortality and postoperative neurological dysfunctions). The systemic immune-inflammation index (SII) is a reliable biomarker for predicting short-term outcomes, including 30-day mortality and neurological dysfunction, after ATAAD repair.
Synapse has enriched 10 related papers. Consider them for comparative context: